Digital Mammography Firms May Meet FDA Requirements Through NCI Trial
This article was originally published in The Gray Sheet
Executive Summary
FDA's recommendation for post-approval studies of digital mammography devices could be moot for devices that are included in the National Cancer Institute-sponsored study scheduled to begin this June, agency officials say.